Revised consolidated earnings forecast for the fiscal year ending December 2025 with revenue at 284.1 billion yen (down 6.6% from previous forecast) and net income attributable to owners of parent at a loss of 3.42 billion yen. Expected exclusion of listing gain from Cullgen\u2019s postponed IPO and recording of impairment loss of 468 million yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2160","jir_company_name":"GNI Group, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/2160-20260123-01.pdf","jir_short_summary":"Revised consolidated earnings forecast for the fiscal year ending December 2025 with revenue at 284.1 billion yen (down 6.6% from previous forecast) and net income attributable to owners of parent at a loss of 3.42 billion yen. Expected exclusion of listing gain from Cullgen\u2019s postponed IPO and recording of impairment loss of 468 million yen.","jir_summary":"### Details of Revised Earnings Forecast\nGNI Group, Inc. has revised its consolidated earnings forecast for the fiscal year ending December 2025, lowering revenue from 28,733 million yen previously forecast to 26,841 million yen, a decrease of 6.6%. Operating income, income before tax, net income, and net income attributable to owners of parent are all expected to significantly decline, with net income forecasted at a loss of 5,937 million yen and net income attributable to owners of parent at a loss of 3,420 million yen. The main reasons for the revision are sales of new pharmaceutical product Etorel\u00ae falling short of initial budget, and exclusion of listing gain of 22,854 million yen due to the postponed NASDAQ IPO of core subsidiary Cullgen, together with recording a full-year operating loss forecast of 3,996 million yen.\n\n### Impairment Loss and Future Outlook\nFollowing impairment tests by independent third parties, GNI Group expects to record a total impairment loss of 468 million yen on goodwill for Miclen Healthcare Co., intangible assets of Shanghai Genomics Technology, and fixed assets of Shanghai Leaf International Trade. Cullgen\u2019s listing remains pending approval; listing gain will be recorded upon IPO completion, although initial stock price and foreign exchange movements could affect the amount. Sales of main product Icerui are progressing well, and both the pharmaceutical and medtech divisions are expected to achieve record-high revenue for the full year.","jir_financial_highlights":"Revenue: 26,841 million yen (6.6% decrease from previous forecast)\nOperating Income: \u25b32,725 million yen (Significant decrease from previous forecast)\nIncome before Tax: \u25b33,795 million yen (Significant decrease from previous forecast)\nNet Income: \u25b35,937 million yen (Significant decrease from previous forecast)\nNet Income Attributable to Owners of Parent: \u25b33,420 million yen (Significant decrease from previous forecast)\nBasic Earnings Per Share: \u25b365.18 yen (Significant decrease from previous forecast)\nExpected Impairment Loss: 468 million yen (New recording)\nExclusion of Cullgen Listing Gain: 22,854 million yen (Excluded)\nCullgen Full-Year Operating Loss Forecast: 3,996 million yen (New recording)","jir_category":"","jir_hashtags":"#GNIGroupInc, #EarningsForecastRevision, #JapaneseStocks","jir_key_figures":"Revenue: 26,841 million yen (6.6% decrease from previous forecast)\nNet Income Attributable to Owners of Parent: \u25b33,420 million yen (significant decrease from previous forecast)\nExpected Impairment Loss: 468 million yen","jir_meta_title":"GNI Group, Inc. Revises 2025 December Fiscal Year Earnings Forecast, Revenue Down to 26,841 Million Yen","jir_meta_description":"GNI Group, Inc. revises consolidated earnings forecast for fiscal year ending December 2025. Revenue expected at 26,841 million yen and net income attributable to owners of parent forecasted at a loss of 3,420 million yen. Announced impact of Cullgen\u2019s IPO postponement and recording of 468 million yen impairment loss.","jir_og_title":"GNI Group Revises Earnings Forecast for Fiscal Year Ending December 2025","jir_og_description":"Revenue forecast at 26,841 million yen with a net loss attributable to owners of parent expected. Impact from Cullgen\u2019s IPO delay and recorded impairment loss.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9370,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-20729","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n